ESR1 and breast carcinoma: This study showed that treatment of ERα-positive MCF7 and T47D breast cancer cells with tamoxifen, a selective estrogen receptor modulator (with antagonistic role in breast tissue), stimulated KISS1/KISS1R expression, implicating that ERα signaling downregulates KISS/KISS1R levels.